Bevacizumab-Based Chemotherapy Combined with Regional Deep Capacitive Hyperthermia in Metastatic Cancer Patients: A Pilot Study

As an angiogenesis inhibitor, bevacizumab has been investigated in combination with different chemotherapeutic agents, achieving an established role for metastatic cancer treatment. However, potential synergic anti-angiogenic effects of hyperthermia have not tested to date in literature. The aim of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Mol Sci
Glavni autori: Ranieri, Girolamo, Ferrari, Cristina, Di Palo, Alessandra, Marech, Ilaria, Porcelli, Mariangela, Falagario, Gianmarco, Ritrovato, Fabiana, Ramunni, Luigi, Fanelli, Margherita, Rubini, Giuseppe, Gadaleta, Cosmo Damiano
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2017
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5535949/
https://ncbi.nlm.nih.gov/pubmed/28684680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18071458
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items